- Home
- SNY vs RXO Comparison
SNY vs RXO Comparison
Compare SNY & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- RXO
- Stock Information
- Founded
- SNY 1994
- RXO 2022
- Country
- SNY France
- RXO United States
- Employees
- SNY N/A
- RXO N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- RXO
- Sector
- SNY Health Care
- RXO
- Exchange
- SNY Nasdaq
- RXO Nasdaq
- Market Cap
- SNY 113.4B
- RXO 2.7B
- IPO Year
- SNY N/A
- RXO N/A
- Fundamental
- Price
- SNY $46.97
- RXO $16.95
- Analyst Decision
- SNY Buy
- RXO Hold
- Analyst Count
- SNY 4
- RXO 15
- Target Price
- SNY $61.50
- RXO $17.77
- AVG Volume (30 Days)
- SNY 2.7M
- RXO 2.0M
- Earning Date
- SNY 10-24-2025
- RXO 11-06-2025
- Dividend Yield
- SNY 3.40%
- RXO N/A
- EPS Growth
- SNY 118.56
- RXO N/A
- EPS
- SNY 8.65
- RXO N/A
- Revenue
- SNY $53,714,621,258.00
- RXO $5,559,000,000.00
- Revenue This Year
- SNY $1.53
- RXO $31.25
- Revenue Next Year
- SNY $7.06
- RXO $6.82
- P/E Ratio
- SNY $5.43
- RXO N/A
- Revenue Growth
- SNY 15.65
- RXO 46.41
- 52 Week Low
- SNY $44.73
- RXO $12.19
- 52 Week High
- SNY $60.12
- RXO $31.98
- Technical
- Relative Strength Index (RSI)
- SNY 43.02
- RXO 55.70
- Support Level
- SNY $46.50
- RXO $16.34
- Resistance Level
- SNY $47.69
- RXO $17.30
- Average True Range (ATR)
- SNY 0.68
- RXO 0.69
- MACD
- SNY -0.18
- RXO 0.08
- Stochastic Oscillator
- SNY 36.14
- RXO 55.73
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.